September 10, 2019

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Tonya K. Aldave

 

Re:	SpringWorks Therapeutics, Inc.
	Registration Statement on Form S-1 (File No. 333-233351)
	Request for Acceleration

 

Dear Ms. Aldave:

 

Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that as of the date hereof, approximately 2,250 copies of the Preliminary Prospectus dated September 3, 2019 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.

 

We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

 

We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Thursday, September 12, 2019 or as soon thereafter as practicable.

 

 

[Signature page follows]

 

 

Very truly yours,

 

J.P. MORGAN SECURITIES LLC

GOLDMAN SACHS & CO. LLC
COWEN AND COMPANY, LLC

 

As representatives of the Underwriters

 

J.P. MORGAN SECURITIES LLC
By:	/s/ David Ke
	Name:	David Ke
	Title:	Executive Director
GOLDMAN SACHS & CO. LLC
By:	/s/ Elizabeth Wood
	Name:	Elizabeth Wood
	Title:	Managing Director
COWEN AND COMPANY, LLC
By:	/s/ David Bohn
	Name:	David Bohn
	Title:	Managing Director